ÂÜÀòÂÒÂ×

Gabor Bethlendy is a seasoned entrepreneur and business leader with significant experience in the life sciences and diagnostics sectors. As the Founder of Gravl, Inc. since June 2023, Gabor aims to facilitate universities in attracting external clients to their research services. Gabor also serves as a Mentor for the Social Impact Cohort at the Cambridge Innovation Center and at the AcexHealth Accelerator through Fundación PTS. Prior to Gravl, Gabor founded and led Meenta Inc. as CEO from May 2017 to December 2022, focusing on improving access to diagnostic testing. As the Founder and Chief Commercial Officer of PARABASE GENOMICS from November 2012 to May 2017, Gabor successfully raised over $5 million and guided the company through its acquisition by Quest Diagnostics. Additional roles include Strategic Collaborations Director at Roche and various positions at Roche NimbleGen Inc. and Combimatrix Corp. Gabor holds a Bachelor of Science in Biochemistry from the University of Rochester and a Master's in Family Therapy from Syracuse University.